These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 5923750)

  • 1. [On the potentiation of DOPA effects by monoamine oxidase inhibitors].
    Boissier JR; Simon P
    Psychopharmacologia; 1966; 8(6):428-36. PubMed ID: 5923750
    [No Abstract]   [Full Text] [Related]  

  • 2. N-substituted cyclopropylamines as monoamine oxidase inhibitors. Structure-activity relationships. Dopa potentiation in mice and in vitro inhibition of kynuramine oxidation.
    Mills J; Kattau R; Slater IH; Fuller RW
    J Med Chem; 1968 Jan; 11(1):95-7. PubMed ID: 4384132
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of dihydroxyphenylalanine administered with a monoamine oxidase inhibitor on glucose metabolism in rat brain.
    Tyce GM
    Biochem Pharmacol; 1971 Sep; 20(9):2371-84. PubMed ID: 5163149
    [No Abstract]   [Full Text] [Related]  

  • 4. Monoamine oxidase and cerebral uptake of dopaminergic drugs.
    Cotzias GC; Tang LC; Ginos JZ
    Proc Natl Acad Sci U S A; 1974 Jul; 71(7):2715-9. PubMed ID: 4137067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Relations between inhibition of cerebral monoamine oxidase in mice and the pyridoxal-5-phosphate-monoamine oxidase inhibitor pharmacological antagonism in the presence of 3,4-dihydroxyphenylalanine].
    Lévy J; Michel-Ber E
    J Physiol (Paris); 1965; 57(4):475-83. PubMed ID: 5848057
    [No Abstract]   [Full Text] [Related]  

  • 6. Central actions of dopa and dopamine.
    Sourkes TL
    Rev Can Biol; 1972; 31():Suppl:153-68. PubMed ID: 4403289
    [No Abstract]   [Full Text] [Related]  

  • 7. The pharmacology of actomol and related compounds.
    Spinks A; Whittle BA
    Int J Neuropharmacol; 1966 Jan; 5(1):125-39. PubMed ID: 4380482
    [No Abstract]   [Full Text] [Related]  

  • 8. Proceedings: The effect of psychotropic drugs on the dopa potentiation test in mice.
    Berendsen H; Leonard BE; Rigter H
    Br J Pharmacol; 1974 Nov; 52(3):432P-433P. PubMed ID: 4458854
    [No Abstract]   [Full Text] [Related]  

  • 9. Anorexigenic activity of L(-) DOPA in animals pretreated with monoaminoxidase inhibitor.
    MANTEGAZZA P; RIVA M
    Med Exp Int J Exp Med; 1961; 4():367-73. PubMed ID: 14469449
    [No Abstract]   [Full Text] [Related]  

  • 10. Dopa-induced excitement in the cat. Its relationship to brain norepinephrine concentrations.
    Reis DJ; Moorhead DT; Merlino N
    Arch Neurol; 1970 Jan; 22(1):31-9. PubMed ID: 4391435
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of the effects of some monoamine oxidase (MAO) inhibitors with 5-hydroxytryptophan (5-HTP) and dihydroxyphenylalanine (DOPA) on spinal synaptic activity.
    Anderson EG; Baker R; Banna N
    Proc West Pharmacol Soc; 1966; 9():40-1. PubMed ID: 5958499
    [No Abstract]   [Full Text] [Related]  

  • 12. [Activity of toloxatone, antidepressive agents and various other reserpine antagonists on three behavior tests, in the mouse treated with nialamide].
    Gouret C; Raynaud G
    Therapie; 1975; 30(2):225-30. PubMed ID: 1080583
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and pharmacology of a pargyline analog, N-3-(1-butynyl)-benzylamine.
    Siuda JF; Cihonski C; Sofia RD; Buckley JP
    J Pharm Sci; 1973 Feb; 62(2):331-2. PubMed ID: 4686418
    [No Abstract]   [Full Text] [Related]  

  • 14. On the hyperglycaemic effect of DOPA and dopamine.
    Håkanson R; Lundquist I; Rerup C
    Eur J Pharmacol; 1967 Mar; 1(2):114-9. PubMed ID: 6060190
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of a ginkgo biloba extract (EGb 761) in functional tests for monoamine oxidase inhibition.
    Porsolt RD; Roux S; Drieu K
    Arzneimittelforschung; 2000 Mar; 50(3):232-5. PubMed ID: 10758773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of dihydroxyphenylalanine on the serotonin content of rat brain following pretreatment with monoamine oxidase inhibitors].
    Popov N; Matthies H
    Acta Biol Med Ger; 1966; 17(5):637-43. PubMed ID: 5991588
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of acylation with eleostearic acids on the monoamine oxidase inhibitory potency of some hydrazine antidepressants in mice.
    Hsu SY; Huang CL; Waters IW
    J Med Chem; 1975 Jan; 18(1):20-3. PubMed ID: 1109570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of L-dopa and inhibitors of decarboxylase and monoamine oxidase on brain noradrenaline levels and blood pressure in spontaneously hypertensive rats.
    Yamori Y; De Jong W; Yamabe H; Lovenberg W; Sjoerdsma A
    J Pharm Pharmacol; 1972 Sep; 24(9):690-5. PubMed ID: 4404071
    [No Abstract]   [Full Text] [Related]  

  • 19. [Structure-action relations of monoamine oxidase inhibitors].
    Matthies H; Fähse C; Lietz W; Jassmann E
    Acta Biol Med Ger; 1967; 19(3):447-61. PubMed ID: 5591162
    [No Abstract]   [Full Text] [Related]  

  • 20. An analysis of DOPA-induced locomotor stimulation in mice with inhibited extracerebral decarboxylase.
    Przegaliński E; Kleinrok Z
    Psychopharmacologia; 1972; 23(3):279-88. PubMed ID: 4260342
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.